Invivyd, Inc. Common Stock
Symbol: IVVD (NASDAQ)
1.30
▼ (-9.44%) -0.135
Company Description:
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
Key Stats
- Today's Open: $1.41
- Today's High: $1.44
- Today's Low: $1.256
- Today's Volume: 2.74M
- Yesterday Close: $1.43
- Yesterday High: $1.45
- Yesterday Low: $1.05
- Yesterday Volume: 10.29M
- Last Min Volume: 200
- Last Min High: $1.295
- Last Min Low: $1.295
- Last Min VWAP: $1.295
Company Profile
- Name: Invivyd, Inc. Common Stock
- Website: https://www.invivyd.com
- Listed Date: 2021-08-06
- Location: WALTHAM, MA
- Market Status: Active
- CIK Number: 0001832038
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $299.41M
- Round Lot: 100
- Outstanding Shares: 209.38M
- Asset Type: CS
RECENT FILINGS FOR IVVD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | SCHEDULE 13G | View |
| 2025-08-29 | SCHEDULE 13G | View |
| 2025-08-27 | SCHEDULE 13G | View |
| 2025-08-26 | SCHEDULE 13D/A | View |
| 2025-08-22 | 8-K | View |
| 2025-08-22 | 424B5 | View |
| 2025-08-20 | FWP | View |
| 2025-08-20 | 424B5 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
Latest News on IVVD